Grantham, Mayo, Van Otterloo & Co (GMO)
PBYI icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Puma Biotechnology PBYI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,010,801
Closed -$59.1M – 610
2016
Q1 		$59.1M Sell
2,010,801
-888,975
-31% -$40.2M 0.22% 93
2015
Q4 		$227M Buy
2,899,776
+1,223,098
+73% +$96M 0.82% 31
2015
Q3 		$126M Buy
1,676,678
+249,940
+18% +$23.6M 0.44% 51
2015
Q2 		$167M Buy
+1,426,738
New +$258M 0.54% 44

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PBYI Position: Q2 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Puma Biotechnology (PBYI) in Q2 2016, closing a stake of 2,010,801 shares — an estimated $59.1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PBYI in Q2 2015 and held it in 4 quarters. The position peaked at $227M in Q4 2015. 110 funds tracked by Wall St. Rank hold PBYI as of Q2 2016.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Puma Biotechnology position as of Q2 2016 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,010,801 Puma Biotechnology shares in Q2 2016, an estimated $59.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Puma Biotechnology in Q2 2015 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Puma Biotechnology position peaked at $227M in Q4 2015.
  • 110 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2016, filed 12 Aug 2016.